Literature DB >> 7997232

Thyroid-specific expression and cyclic adenosine 3',5'-monophosphate autoregulation of the thyrotropin receptor gene involves thyroid transcription factor-1.

H Shimura1, F Okajima, S Ikuyama, Y Shimura, S Kimura, M Saji, L D Kohn.   

Abstract

The chimeric chloramphenicol acetyltransferase (CAT) construct, pTRCAT5'-199, containing the TSH receptor (TSHR) minimal promoter, -199 to -39 base pairs (bp), exhibits the thyroid specificity and TSH/cAMP autoregulation evident in TSHR gene expression. The present report shows that a cis-acting element between -189 and -175 bp, which binds thyroid transcription factor-1 (TTF-1), is involved in both activities. The 22 bp between -199 and -178 contains a positive element important for expression of the TSHR minimal promoter in rat FRTL-5 thyroid cells. DNAase I footprinting shows that extracts from functioning FRTL-5, but not non-functioning FRT thyroid or Buffalo rat liver (BRL) cells, protect a region between -189 and -175 bp. The protection is duplicated by TTF-1, and the protected element has only a two-base mismatch from the consensus TTF-1 element identified in the thyroglobulin (TG) and thyroid peroxidase minimal promoters. Gel mobility shift analyses reveal that FRTL-5 thyroid cell nuclear extracts form a specific protein/DNA complex with this region, which is prevented by the TTF-1 binding element from the TG promoter; FRT and BRL cell nuclear extracts do not have TTF-1 and do not form this complex. A role for the TSHR/TTF-1 binding element in thyroid-specific expression of the TSHR gene is evidenced as follows. Overexpression of TTF-1 in FRT or BRL cells, which have no TTF-1, increased the activity of pTRCAT5'-199, but not pTRCAT5'-177, which has no TTF-1 binding element. A nonsense mutation of the TTF-1 binding element eliminated TTF-1-induced activation of TSHR promoter activity in FRT or BRL cells and reduced TSHR promoter activity in FRTL-5 thyroid cells. In contrast, mutation of this element to the TTF-1 consensus sequence of the TG or thyroid peroxidase promoter had no significant influence on TSHR promoter activity. The activity of the TSHR/TTF-1 binding element requires a functioning cAMP response element (CRE). Thus, TTF-1 activity is lost when the CRE site is mutated to a nonfunctional, nonpalindromic sequence; it is, in contrast, maximized when CRE activity is maximized by its mutation to a consensus AP1 element. TTF-1 phosphorylation is important for binding and activity. Thus, binding of TTF-1 to the TSHR/TTF-1 element is phosphatase-sensitive and is increased by treating nuclear extracts with the catalytic subunit of protein kinase A. Overexpression of the catalytic subunit of PKA enhances TTF-1-increased activity of the TSHR minimal promoter.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7997232     DOI: 10.1210/mend.8.8.7997232

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  19 in total

1.  Expression of hypothalamic-pituitary-thyroid axis related genes in the human skin.

Authors:  Andrzej Slominski; Jacobo Wortsman; Leonard Kohn; Kenneth B Ain; Gopalakrishnan M Venkataraman; Alexander Pisarchik; Jae Hoon Chung; Cesidio Giuliani; Mark Thornton; George Slugocki; Desmond J Tobin
Journal:  J Invest Dermatol       Date:  2002-12       Impact factor: 8.551

2.  A transgene targeted to the zebrafish nkx2.4b locus drives specific green fluorescent protein expression and disrupts thyroid development.

Authors:  David A Hutcheson; Yuanyuan Xie; Priscilla Figueroa; Richard I Dorsky
Journal:  Dev Dyn       Date:  2020-08-05       Impact factor: 3.780

3.  Increased peroxisomal fatty acid beta-oxidation and enhanced expression of peroxisome proliferator-activated receptor-alpha in diabetic rat liver.

Authors:  K Asayama; R Sandhir; F G Sheikh; H Hayashibe; T Nakane; I Singh
Journal:  Mol Cell Biochem       Date:  1999-04       Impact factor: 3.396

4.  Thyroid transcription factor-1 in orbital adipose tissues: potential role in orbital thyrotropin receptor expression.

Authors:  Kalyan K Bhattacharyya; Michael J Coenen; Rebecca S Bahn
Journal:  Thyroid       Date:  2005-05       Impact factor: 6.568

5.  Thyroglobulin repression of thyroid transcription factor 1 (TTF-1) gene expression is mediated by decreased DNA binding of nuclear factor I proteins which control constitutive TTF-1 expression.

Authors:  M Nakazato; H K Chung; L Ulianich; A Grassadonia; K Suzuki; L D Kohn
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

6.  Thyroid-specific enhancer-binding protein/NKX2.1 is required for the maintenance of ordered architecture and function of the differentiated thyroid.

Authors:  Takashi Kusakabe; Akio Kawaguchi; Nobuo Hoshi; Rumi Kawaguchi; Sayuri Hoshi; Shioko Kimura
Journal:  Mol Endocrinol       Date:  2006-04-06

7.  Gbetagamma dimers released in response to thyrotropin activate phosphoinositide 3-kinase and regulate gene expression in thyroid cells.

Authors:  Miguel A Zaballos; Bibian Garcia; Pilar Santisteban
Journal:  Mol Endocrinol       Date:  2008-01-17

8.  Autoregulation of thyroid-specific gene transcription by thyroglobulin.

Authors:  K Suzuki; S Lavaroni; A Mori; M Ohta; J Saito; M Pietrarelli; D S Singer; S Kimura; R Katoh; A Kawaoi; L D Kohn
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

9.  Role of NKX2-1 in N-bis(2-hydroxypropyl)-nitrosamine-induced thyroid adenoma in mice.

Authors:  Sayuri Hoshi; Nobuo Hoshi; Minoru Okamoto; Jorge Paiz; Takashi Kusakabe; Jerrold M Ward; Shioko Kimura
Journal:  Carcinogenesis       Date:  2009-07-06       Impact factor: 4.944

10.  Thyroid transcription factor 1 is calcium modulated and coordinately regulates genes involved in calcium homeostasis in C cells.

Authors:  K Suzuki; S Lavaroni; A Mori; F Okajima; S Kimura; R Katoh; A Kawaoi; L D Kohn
Journal:  Mol Cell Biol       Date:  1998-12       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.